“Role of Gut Microbiota in Neurotransmitter Regulation and Brain Function: A Review”
International Journal of Creative and Open Research in Engineering and Management · 29.06.2026 · 02 (06) · 1-13
DOI: 10.55041/ijcope.v2i6.376 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Creative and Open Research in Engineering and Management, online erschienen am 29.06.2026. Verfasst von Samir Moirangthem Samir Moirangthem und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The gut microbiota constitutes a complex ecosystem of trillions of microorganisms that exert profound effects on host physiology, including brain function and behavior. The bidirectional communication network between the gastrointestinal tract and the central nervous system, termed the gut-brain axis, has emerged as a critical regulator of neurological health. Objective:This review synthesizes current evidence from peer-reviewed literature on the mechanisms by which gut microbiota modulate neurotransmitter systems and influence brain function, with emphasis on clinical translation and diagnostic applications.
Methods
A systematic literature search was conducted using PubMed and Scopus databases (2015–2026) with Boolean operators: ("gut microbiota" OR "gut microbiome") AND ("neurotransmitters" OR "serotonin" OR "dopamine" OR "GABA") AND ("brain function" OR "gut-brain axis"). Inclusion criteria comprised peer-reviewed original research and review articles in English, with preference for studies published in the last decade. The selection process followed PRISMA guidelines, yielding 127 articles for full-text review and 68 for final synthesis.
Results
Emerging evidence demonstrates that gut bacteria produce or modulate multiple neuroactive compounds, including serotonin, dopamine, gamma-aminobutyric acid (GABA), and short-chain fatty acids. Commensal species such as Enterococcus faecalis synthesize dopamine, while Escherichia coli and Blautia producta generate GABA. Microbial metabolites influence brain function through neural (vagus nerve), endocrine (hypothalamic-pituitary-adrenal axis), and immune pathways. Dysbiosis is consistently associated with neuropsychiatric conditions including depression, anxiety, and neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Clinical applications, including microbiome-based biomarkers and therapeutic interventions (probiotics, prebiotics, fecal microbiota transplantation), show promise but require validation through large-scale randomized controlled trials.
Conclusion
The gut microbiota represents a modifiable target for neurological and psychiatric interventions. Future research must establish causality through mechanistic studies and develop standardized protocols for clinical translation. Keywords: gut microbiota; gut-brain axis; neurotransmitters; GABA;; neuroinflammation
Zitieren
APA
Moirangthem, S. M. S., Kom, H. W. K. H. W., Ango, M. A. M., Singha, H. S. H., N.Sangma, J. N. J., & Gangmei, G. G. G. (2026). “Role of Gut Microbiota in Neurotransmitter Regulation and Brain Function: A Review”. International Journal of Creative and Open Research in Engineering and Management, 02(06), 1-13. https://doi.org/10.55041/ijcope.v2i6.376
Vancouver
Moirangthem SMS, Kom HWKHW, Ango MAM, Singha HSH, N.Sangma JNJ, Gangmei GGG. “Role of Gut Microbiota in Neurotransmitter Regulation and Brain Function: A Review”. International Journal of Creative and Open Research in Engineering and Management. 2026;02(06):1-13. doi:10.55041/ijcope.v2i6.376
BibTeX
@article{Moirangthem2026,
author = {Moirangthem, Samir Moirangthem Samir and Kom, Hmangte Wendy Kom Hmangte Wendy and Ango, Marli Ango Marli and Singha, H.Suraj Singha H.Suraj and N.Sangma, Jackricky N.Sangma Jackricky and Gangmei, Gunlu Gangmei Gunlu},
title = {“Role of Gut Microbiota in Neurotransmitter Regulation and Brain Function: A Review”},
journal = {International Journal of Creative and Open Research in Engineering and Management},
year = {2026},
volume = {02},
number = {06},
pages = {1--13},
doi = {10.55041/ijcope.v2i6.376}
}
EUVIMED